dc.creatorGonzalez, Patricia Verónica
dc.creatorMachado, Ivana Noelia
dc.creatorVilcaes, Aldo Alejandro
dc.creatorCaruso, Carla Mariana
dc.creatorRoth, German Alfredo
dc.creatorSchiöth, H.
dc.creatorLasaga, Mercedes Isabel
dc.creatorScimonelli, Teresa Nieves
dc.date.accessioned2017-04-10T20:47:54Z
dc.date.accessioned2018-11-06T12:25:44Z
dc.date.available2017-04-10T20:47:54Z
dc.date.available2018-11-06T12:25:44Z
dc.date.created2017-04-10T20:47:54Z
dc.date.issued2013-10
dc.identifierGonzalez, Patricia Verónica; Machado, Ivana Noelia; Vilcaes, Aldo Alejandro; Caruso, Carla Mariana; Roth, German Alfredo; et al.; Molecular mechanisms involved in interleukin 1-beta (IL-1b)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (a-MSH); Elsevier; Brain Behavior And Immunity; 34; 10-2013; 141-150
dc.identifier0889-1591
dc.identifierhttp://hdl.handle.net/11336/15109
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1866473
dc.description.abstractPro-inflammatory cytokines can affect cognitive processes such as learning and memory. Particularly, interleukin-1β (IL-1β) influences the consolidation of hippocampus-dependent memories. We previously reported that administration of IL-1β in dorsal hippocampus impaired contextual fear memory consolidation. Different mechanisms have been implicated in the action of IL-1β on long-term potentiation (LTP), but the processes by which this inhibition occurs in vivo remain to be elucidated. We herein report that intrahippocampal injection of IL-1β induced a significant increase in p38 phosphorylation after contextual fear conditioning. Also, treatment with SB203580, an inhibitor of p38, reversed impairment induced by IL-1β on conditioned fear behavior, indicating that this MAPK would be involved in the effect of the cytokine. We also showed that IL-1β administration produced a decrease in glutamate release from dorsal hippocampus synaptosomes and that treatment with SB203580 partially reversed this effect. Our results indicated that IL-1β-induced impairment in memory consolidation could be mediated by a decrease in glutamate release. This hypothesis is sustained by the fact that treatment with d-cycloserine (DCS), a partial agonist of the NMDA receptor, reversed the effect of IL-1β on contextual fear memory. Furthermore, we demonstrated that IL-1β produced a temporal delay in ERK phosphorylation and that DCS administration reversed this effect. We also observed that intrahippocampal injection of IL-1β decreased BDNF expression after contextual fear conditioning. We previously demonstrated that α-MSH reversed the detrimental effect of IL-1β on memory consolidation. The present results demonstrate that α-MSH administration did not modify the decrease in glutamate release induced by IL-1β. However, intrahippocampal injection of α-MSH prevented the effect on ERK phosphorylation and BDNF expression induced by IL-1β after contextual fear conditioning. Therefore, in the present study we determine possible molecular mechanisms involved in the impairment induced by IL-1β on fear memory consolidation. We also established how this effect could be modulated by α-MSH.
dc.languageeng
dc.publisherElsevier
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0889159113004182
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bbi.2013.08.007
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectIL-1BETA
dc.subjectMEMORY CONSOLIDATION
dc.subjectALPHA-MSH
dc.subjectGLUTAMATE RELEASE
dc.subjectP38
dc.subjectERK
dc.subjectBDNF
dc.titleMolecular mechanisms involved in interleukin 1-beta (IL-1b)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (a-MSH)
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución